Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Autor: Reichert ZR; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Kasputis T; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Nallandhighal S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Abusamra SM; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Kasputis A; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Haruray S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Wang Y; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Williams S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Singhal U; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, Mayo Clinic, Rochester, MN 55901, USA., Alva A; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA., Cackowski FC; Division of Medical Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA., Caram MEV; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Palmbos PL; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Yentz SE; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Lieutenant Colonel Charles S. Kettles VA Medical Center, Ann Arbor, MI 48105, USA., Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Alumkal JJ; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA., Morgan TM; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 21; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 21.

Implementation of a Multidisciplinary Care Pathway via an Emergency Department-ICU to Improve Care of Emergency Department Patients Presenting With Leukostasis.

Autor: Haas NL; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI.; Department of Emergency Medicine, Division of Critical Care, University of Michigan, Ann Arbor, MI., Nafday A; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI., Cranford JA; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI., Yentz SE; Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI., Bixby DL; Department of Internal Medicine, Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI., Bassin BS; Department of Emergency Medicine, University of Michigan, Ann Arbor, MI.; Department of Emergency Medicine, Division of Critical Care, University of Michigan, Ann Arbor, MI.; Michigan Center for Integrative Research in Critical Care, University of Michigan, Ann Arbor, MI.

Publikováno v: Critical care explorations [Crit Care Explor] 2020 Feb 24; Vol. 2 (2), pp. e0084. Date of Electronic Publication: 2020 Feb 24 (Print Publication: 2020).

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

Autor: Gentzler RD; Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois., Yentz SE, Johnson ML, Rademaker AW, Patel JD

Publikováno v: Cancer [Cancer] 2014 Dec 15; Vol. 120 (24), pp. 3853-8. Date of Electronic Publication: 2014 Aug 25.